marijuana stocks

GW Pharmaceuticals (GWPH) Jumps: Stock Rises 13.1% – Tale of the Tape

GW Pharmaceuticals plc (GWPH) was a big mover last session with its shares rising just over 13% on the day. The upside was owing to the company’s announcement that the American Academy of Neurology (AAN) has released data from physician-led FDA authorized Epidiolex “expanded access” programs for children and young adults with treatment-resistant epilepsy who have exhausted available treatment options. This development led to far more shares changing hands yesterday than in a normal session. This breaks the recent trend of the company as the stock is now trading above the past one month’s volatile price range of $86.46 to $100.48.

This biopharmaceutical company has seen no estimate revision in the last 30 days. The Zacks Consensus Estimate hasn’t been in trend either. Yesterday’s rally is encouraging though, so make sure to keep a close watch on this firm in the near future.

GW Pharmaceuticals currently holds a Zacks Rank #2 (Buy) while its Earnings ESP is 0.00%.


MAPH Enterprises, LLC | (305) 414-0128 | 1501 Venera Ave, Coral Gables, FL 33146 | new@marijuanastocks.com
Leave a Reply

Your email address will not be published. Required fields are marked *

You May Also Like

Emblem Corp. (EMMBF) and Dosecann Inc. Sign Licensing Deal

Emblem Corp. and Dosecann Inc. Sign Licensing Deal to Develop Dosage-Controlled Formulations…

MassRoots, Inc. (MSRT) CEO joins Uptick Newswire’s Stock Day Podcast

MassRoots, Inc.’s CEO joins Uptick Newswire’s Stock Day Podcast to Talk About…

$QEDN Acquisition, Green M&A Solutions, Provides RFP to USAID/Colombia

QED Connect Inc. Acquisition, Green M&A Solutions, Provides RFP to USAID/Colombia MANCHESTER,…

$FFRMF to Manage Cannabis Cultivation Facility

Future Farm Subsidiary to Manage Cannabis Cultivation Facility Future Farm Technologies Inc.…